US Stock MarketDetailed Quotes

NTLA Intellia Therapeutics

Watchlist
  • 24.800
  • -0.370-1.47%
Close Jun 18 16:00 ET
  • 24.700
  • -0.100-0.40%
Post 19:59 ET
2.39BMarket Cap-4618P/E (TTM)

Intellia Therapeutics Stock Analyst Ratings & Price Target

Analyst Rating

Updated: Jun 19, 2024

Based on 18 analysts giving stock ratings to Intellia Therapeutics in the past 3 months

Strong Buy

  • Buy

    77.78%
  • Hold

    22.22%
  • Sell

    0.00%

Price Target

Updated: Jun 19, 2024

The average Intellia Therapeutics stock price target is 62.29 with a max estimate of 95.00 and a min estimate of 24.00

Detailed RatingsDetailed RatingsDetailed Ratings

Detailed Ratings

Receive timely notifications of rating changes

View more detailed ratings of institutions and analysts

View rating details page for historical data

Download APP

Analyst Ratings Disclaimer

Analysis

Analyst Rating

Updated: Jun 19, 2024

Strong Buy

  • Buy

    77.78%
  • Hold

    22.22%
  • Sell

    0.00%

Price Target

Updated: Jun 19, 2024

Heat List
US
Overall
Symbol
Latest Price
%Chg